| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |